- Home
- AUROW vs VCEL Comparison
AUROW vs VCEL Comparison
Compare AUROW & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUROW | VCEL |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | United States | United States |
| Employees | 1900 | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 1.7B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | AUROW | VCEL |
|---|---|---|
| Price | $0.21 | $32.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $58.50 |
| AVG Volume (30 Days) | 18.9K | ★ 467.7K |
| Earning Date | 04-30-2025 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.00 |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | ★ $276,259,000.00 |
| Revenue This Year | N/A | $19.09 |
| Revenue Next Year | N/A | $17.96 |
| P/E Ratio | ★ N/A | $101.36 |
| Revenue Growth | N/A | ★ 16.45 |
| 52 Week Low | $0.16 | $29.24 |
| 52 Week High | $1.98 | $48.75 |
Technical Indicators
Market Signals| Indicator | AUROW | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 37.63 | 35.04 |
| Support Level | $0.16 | $31.34 |
| Resistance Level | $0.30 | $38.48 |
| Average True Range (ATR) | 0.03 | 1.24 |
| MACD | -0.00 | -0.23 |
| Stochastic Oscillator | 10.00 | 20.11 |
Price Performance
Historical ComparisonAbout AUROW Aurora Innovation Inc. Warrant
Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, a scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.